Hahn will Bring Unparalleled Experience in Drug Development to Growing Biotech Firm (CLEVELAND, OH) – Stephen Hahn, MD, 24th Commissioner of Food and Drugs and the former chief medical executive...
Tag: News
Novel SA53 MDM2 Inhibitor Therapy Has Potential to be a Breakthrough in Genetically-Targeted Cancer Treatment (CLEVELAND, OH) – Lamassu Biotech, a clinical-stage pharmaceutical company, today announced a significant clinical milestone...
A new type of cancer drug could transform the treatment for many deadly cancers, especially those that have advanced or metastasized and do not respond to other therapies. Rather than...